Literature DB >> 8280813

Reduction of HTLV-I-infected cells in blood by leukocyte filtration.

E J Al1, S C Visser, S M Broersen, S Stienstra, J G Huisman.   

Abstract

Leukocyte filtration was performed with HTLV-I-infected blood and with blood supplemented with cultured HTLV-I-transformed cells. Reduction of infectivity upon leukocyte filtration was determined by the polymerase chain reaction (PCR) using primers indicative for the HTLV-I-pol and tax genes. Two different commercially available filters were used: a column-shaped cellulose acetate and a flat-bed polyester filter. Both filters yielded reduction of at least 3 10logs for cultured HTLV-I-infected cells. When blood from HTLV-I-infected individuals was used for filtration, the number of infected cells was reduced by 1-3 10logs. Although filtered blood as yet cannot be regarded as safe, it is concluded that leukocyte filtration of HTLV-I-infected blood potentially contributes to reducing the spread of HTLV-I by blood transfusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280813     DOI: 10.1007/BF01696350

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

Review 1.  The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

Authors:  A Manns; W A Blattner
Journal:  Transfusion       Date:  1991-01       Impact factor: 3.157

2.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.

Authors:  T Kinoshita; M Shimoyama; K Tobinai; M Ito; S Ito; S Ikeda; K Tajima; K Shimotohno; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA.

Authors:  D B Duggan; G D Ehrlich; F P Davey; S Kwok; J Sninsky; J Goldberg; L Baltrucki; B J Poiesz
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

4.  Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.

Authors:  H H Lee; P Swanson; J D Rosenblatt; I S Chen; W C Sherwood; D E Smith; G E Tegtmeier; L P Fernando; C T Fang; M Osame
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

6.  Lymphocyte function-associated antigen 1 (LFA-1) is a marker of mature (immunocompetent) lymphoid cells. A survey of lymphoproliferative diseases in man.

Authors:  F Miedema; J F Tromp; M B van't Veer; S Poppema; C J Melief
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

7.  Prevalence of human T-cell leukemia virus antibody among heterosexuals living in Amsterdam, The Netherlands.

Authors:  G J van Doornum; C Hooykaas; J G Huisman; M M van der Linden; R A Coutinho
Journal:  J Med Virol       Date:  1990-11       Impact factor: 2.327

8.  Enhanced detection of HIV-1 sequences using polymerase chain reaction and a liquid hybridization technique. Application for individuals with questionable HIV-1 infection.

Authors:  S M Bruisten; M H Koppelman; C L van der Poel; J G Huisman
Journal:  Vox Sang       Date:  1991       Impact factor: 2.144

9.  Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.

Authors:  J A van den Hoek; E J Al; J G Huisman; J Goudsmit; R A Coutinho
Journal:  J Med Virol       Date:  1991-06       Impact factor: 2.327

10.  Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction.

Authors:  S Saito; K Furuki; Y Ando; T Tanigawa; K Kakimoto; I Moriyama; M Ichijo
Journal:  Jpn J Cancer Res       Date:  1990-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.